Revelation Biosciences, Inc.
REVB
$3.14
$0.06252.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12,400.83% | -1,873.22% | -781.72% | -560.43% | 98.89% |
| Total Depreciation and Amortization | 10.71% | 7.14% | 3.57% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 101.38% | 100.08% | 99.00% | 93.42% | -2,684.82% |
| Change in Net Operating Assets | -448.56% | -212.37% | 1,253.80% | 137.02% | 234.37% |
| Cash from Operations | -151.45% | -166.03% | -44.68% | -7.34% | 35.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -8.43% | -34.71% | -70.69% | -70.69% | 19.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 100.00% | 100.00% | 100.00% | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.39% | -34.71% | -70.69% | -70.69% | -7.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.51% | -195.57% | -129.74% | -129.96% | 69.39% |